Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
暂无分享,去创建一个
G. Kang | M. Lipsitch | D. Vaughn | B. Cowling | S. Schrag | Peter G. Smith | M. Valenciano | J. Bresee | R. Pebody | A. Wilder-Smith | D. Feikin | M. Katz | N. Crowcroft | C. Lanata | J. Ortiz | W. Orenstein | J. Verani | I. Bergeri | Minal K. Patel | S. Hirve | P. Srikantiah | J. Mwenda | Sudhir Joshi | L. Subissi | F. Nogareda | Kamal Fahmy | Maïna L'Azou Jackson | K. Fahmy | M. Patel
[1] Aaloke Mody,et al. Review 2: "FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system" , 2021 .
[2] M. Lipsitch,et al. Interpreting vaccine efficacy trial results for infection and transmission , 2021, Vaccine.
[3] M. Hernán,et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.
[4] A. Charlett,et al. Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) , 2021, SSRN Electronic Journal.
[5] Colin Simpson,et al. Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People , 2021, SSRN Electronic Journal.
[6] A. Venkatakrishnan,et al. FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system , 2021, medRxiv.
[7] R. Kishony,et al. Decreased SARS-CoV-2 viral load following vaccination , 2021, medRxiv.
[8] M. Fay,et al. Vaccine Efficacy at a Point in Time , 2021, medRxiv.
[9] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[10] J. Sterne,et al. Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.
[11] M. Lipsitch,et al. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials , 2020, Nature Medicine.
[12] M. Lipsitch,et al. Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results , 2019, Epidemiology and Infection.
[13] M Elizabeth Halloran,et al. Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design , 2019, American journal of epidemiology.
[14] N. Andrews,et al. The use of quasi-experimental designs for vaccine evaluation. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M. Kulldorff,et al. Intra-season Waning of Influenza Vaccine Effectiveness. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] M. Lipsitch. Challenges of vaccine effectiveness and waning studies. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] M. Lipsitch,et al. Measurement of Vaccine Direct Effects Under the Test-Negative Design. , 2018, American journal of epidemiology.
[18] K. Bollaerts,et al. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness , 2018, PloS one.
[19] M. Hernán,et al. The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening , 2017, European Journal of Epidemiology.
[20] Nicholas S. Kelley,et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.
[21] Kenneth J Rothman,et al. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. , 2015, Vaccine.
[22] Benjamin J Cowling,et al. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review , 2014, Expert review of vaccines.
[23] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[24] Xiaolin Zhang,et al. EFFECTIVENESS , 1977, Prospects for Constitutionalism in Post-Communist Countries.
[25] C. E.. WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .
[26] W. Organization. - 1-Diagnostic testing for SARS-CoV-2 Interim guidance 11 September 2020 , 2020 .
[27] A R Hinman,et al. Field evaluation of vaccine efficacy. , 1985, Bulletin of the World Health Organization.